Related Experiment Video

Updated: May 4, 2026

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

10.5K

Intermittent or sustained systemic inflammation and the preterm brain

Olaf Dammann1, Alan Leviton2

  • 11] Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts [2] Division of Newborn Medicine, Department of Neurology, Floating Hospital for Children at Tufts Medical Center,, Boston, Massachusetts [3] Perinatal Neuroepidemiology Unit, Hannover Medical School, Hannover, Germany.

Pediatric Research
|January 17, 2014
PubMed

Insights

Perinatal infection and inflammation increase neonatal brain damage risk. Sustained systemic inflammation in preterm infants is linked to worse neurodevelopmental outcomes compared to shorter inflammation periods.

Area of Science:

  • Neonatal neurology
  • Perinatal medicine
  • Developmental neuroscience

Background:

  • Perinatal infection and inflammation are known risk factors for neonatal brain damage and developmental disabilities.
  • The duration and pattern of inflammatory responses in newborns are critical factors influencing neurodevelopmental outcomes.

Purpose of the Study:

  • To review evidence on intermittent or sustained systemic inflammation (ISSI) in preterm newborns.
  • To elucidate the role of ISSI in adverse neurodevelopmental outcomes in preterm infants.

Main Methods:

  • Integrated mechanism review of existing scientific literature.
  • Analysis of evidence linking perinatal inflammation patterns to neurodevelopmental trajectories.

Main Results:

  • Preterm newborns can experience intermittent or sustained systemic inflammation (ISSI).
  • ISSI appears to be a more significant contributor to adverse neurodevelopmental outcomes in preterm infants than shorter-duration inflammation.

Conclusions:

  • The pattern and duration of systemic inflammation are crucial in determining neurodevelopmental outcomes in preterm infants.
  • Targeting and managing sustained inflammation in preterm neonates may be key to preventing developmental disabilities.

More Related Videos

A Ferret Model of Inflammation-sensitized Late Preterm Hypoxic-ischemic Brain Injury07:36

A Ferret Model of Inflammation-sensitized Late Preterm Hypoxic-ischemic Brain Injury

Published on: November 19, 2019

6.8K
Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats04:12

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats

Published on: March 28, 2025

717

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
24
Gut-Brain Axis01:22

Gut-Brain Axis

The gut–brain axis is a bidirectional communication system that connects the gastrointestinal tract and the brain. This interaction is mediated through multiple pathways, including the vagus nerve, hormonal signals, immune responses, and chemical messengers produced by gut microbes.Microbial Contributions to Brain FunctionGut microbiota contributes significantly to brain function by producing neuroactive compounds. These include neuroactive compounds that influence neurotransmitters such...
222
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
19
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
22
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
41
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial...
21